Zoetis Inc (ZTS)
167.07
-0.16
(-0.10%)
USD |
NYSE |
May 03, 16:00
167.02
-0.06
(-0.03%)
After-Hours: 20:00
Zoetis Cash from Operations (Quarterly): 595.00M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 595.00M |
December 31, 2023 | 897.00M |
September 30, 2023 | 724.00M |
June 30, 2023 | 183.00M |
March 31, 2023 | 549.00M |
December 31, 2022 | 741.00M |
September 30, 2022 | 526.00M |
June 30, 2022 | 336.00M |
March 31, 2022 | 309.00M |
December 31, 2021 | 679.00M |
September 30, 2021 | 653.00M |
June 30, 2021 | 481.00M |
March 31, 2021 | 400.00M |
December 31, 2020 | 718.00M |
September 30, 2020 | 562.00M |
June 30, 2020 | 438.00M |
March 31, 2020 | 408.00M |
December 31, 2019 | 582.00M |
September 30, 2019 | 506.00M |
June 30, 2019 | 318.00M |
March 31, 2019 | 389.00M |
December 31, 2018 | 584.00M |
September 30, 2018 | 550.00M |
June 30, 2018 | 267.00M |
March 31, 2018 | 389.00M |
Date | Value |
---|---|
December 31, 2017 | 608.00M |
September 30, 2017 | 439.00M |
June 30, 2017 | 180.00M |
March 31, 2017 | 119.00M |
December 31, 2016 | 286.00M |
September 30, 2016 | 239.00M |
June 30, 2016 | 137.00M |
March 31, 2016 | 51.00M |
December 31, 2015 | 278.00M |
September 30, 2015 | 204.00M |
June 30, 2015 | 122.00M |
March 31, 2015 | 60.00M |
December 31, 2014 | 387.00M |
September 30, 2014 | 103.00M |
June 30, 2014 | 159.00M |
March 31, 2014 | -23.00M |
December 31, 2013 | 298.00M |
September 30, 2013 | 114.00M |
June 30, 2013 | -12.00M |
March 31, 2013 | 281.00M |
December 31, 2012 | 310.00M |
September 30, 2012 | 74.00M |
June 30, 2012 | 74.00M |
March 31, 2012 | -4.00M |
December 31, 2011 | 114.00M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
183.00M
Minimum
Jun 2023
897.00M
Maximum
Dec 2023
530.25M
Average
537.50M
Median
Cash from Operations (Quarterly) Benchmarks
Biogen Inc | 553.20M |
Pfizer Inc | 5.24B |
Eli Lilly and Co | 1.166B |
Bristol-Myers Squibb Co | 2.834B |
Amgen Inc | 689.00M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -131.00M |
Cash from Financing (Quarterly) | -524.00M |
Free Cash Flow | 1.75B |
Free Cash Flow Per Share (Quarterly) | 0.9917 |
Free Cash Flow to Equity (Quarterly) | 436.00M |
Free Cash Flow to Firm (Quarterly) | 475.85M |
Free Cash Flow Yield | 2.27% |